Pharma Industry Events & Conferences

Home
Drug Development
Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Full service: the expertise and efficiency of a one-stop shop

UCB and Microsoft expand drug development partnership

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

AstraZeneca and IDT Biologika sign LOI to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

GSK and CureVac to develop next generation mRNA COVID-19 vaccines
Manufacturing
Supply Chain
Facilities
Health & Nutrition
Events
Contact Us

No Result

View All Result

No Result

View All Result

No Result

View All Result

Home Events & Conferences

Apr

2021

Reuters Events Pharma: Clinical 2021

April 7 - April 9, 2021

Virtual , Virtual , Virtual

The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU clinical leaders created to harness this mom

Details

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Full service: the expertise and efficiency of a one-stop shop

UCB and Microsoft expand drug development partnership

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

AstraZeneca and IDT Biologika sign LOI to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Full service: the expertise and efficiency of a one-stop shop

UCB and Microsoft expand drug development partnership

Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease

AstraZeneca and IDT Biologika sign LOI to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

Reuters Events Pharma: Clinical 2021

About Us

Qucik Links

Resources

System

Retrieve your password